Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study. 2007

Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
Department of Antibody Engineering, Center of Molecular Immunology, PO Box 16040, Havana 11600, Cuba.

The antibody heavy chain is generally more important than the light chain for the interaction with the antigen, although many reports demonstrate the influence of the light chain in the antibody binding properties. The heavy chains of anti-N-glycolyl-ganglioside P3 mAb and anti-idiotypic 1E10 mAb display complementary charged residues in their H-CDRs, particularly in H-CDR3. A basic residue in P3 mAb H-CDR1 was shown to be crucial for the interaction with the antigen and 1E10 mAb. The immunogenetic features of three other P3 mAb anti-idiotypic mAbs are now analyzed. One of them bears the same heavy chain as 1E10 mAb and a different light chain, but differs in its binding to P3 mAb mutants where H-CDR basic residues were replaced and in the binding to 1E10-specific phagotopes. Chimeric hybrid antibodies with P3 and 1E10 mAb heavy chains and unrelated light chains were obtained to further determine the importance of heavy chains in P3 and 1E10 mAb binding properties. One of the P3 heavy chain hybrid antibodies retained the specificity of P3 mAb with slight affinity differences. The heavy chains appear to play the main role in these mAb interactions, with the light chains modulating the affinity to their ligands.

UI MeSH Term Description Entries
D007130 Immunoglobulin Idiotypes Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains. Idiotypes, Immunoglobulin,Ig Idiotypes,Idiotype, Ig,Idiotype, Immunoglobulin,Idiotypes, Ig,Ig Idiotype,Immunoglobulin Idiotype
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D005678 G(M2) Ganglioside A glycosphingolipid that accumulates due to a deficiency of hexosaminidase A or B (BETA-N-ACETYLHEXOSAMINIDASES), or GM2 activator protein, resulting in GANGLIOSIDOSES, heredity metabolic disorders that include TAY-SACHS DISEASE and SANDHOFF DISEASE. GM2 Ganglioside,Tay-Sachs Disease Ganglioside,Ganglioside GM2,GM2, Ganglioside,Ganglioside, GM2,Ganglioside, Tay-Sachs Disease,Tay Sachs Disease Ganglioside
D005679 G(M3) Ganglioside A ganglioside present in abnormally large amounts in the brain and liver due to a deficient biosynthetic enzyme, G(M3):UDP-N-acetylgalactosaminyltransferase. Deficiency of this enzyme prevents the formation of G(M2) ganglioside from G(M3) ganglioside and is the cause of an anabolic sphingolipidosis. Hematoside,Sialyllactosylceramide,Ganglioside GM3,II3NeuAcLacCer,Sialyl Lactosylceramide,GM3, Ganglioside,Lactosylceramide, Sialyl
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000888 Antibodies, Anti-Idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. Anti-Antibodies,Anti-Idiotype Antibodies,Antibodies, Internal Image,Antigamma Globulin Antibodies,Antiglobulins,Anti Antibodies,Anti-gamma Globulin Antibodies,Anti Idiotype Antibodies,Anti gamma Globulin Antibodies,Anti-Idiotypic Antibodies,Antibodies, Anti,Antibodies, Anti Idiotypic,Antibodies, Anti-Idiotype,Antibodies, Anti-gamma Globulin,Antibodies, Antigamma Globulin,Globulin Antibodies, Anti-gamma,Globulin Antibodies, Antigamma,Image Antibodies, Internal,Internal Image Antibodies

Related Publications

Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
January 2007, Molecular immunology,
Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
April 2007, Molecular immunology,
Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
April 2007, Molecular immunology,
Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
December 1990, Bollettino della Societa italiana di biologia sperimentale,
Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
August 1988, Journal of immunology (Baltimore, Md. : 1950),
Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
September 1987, Journal of immunology (Baltimore, Md. : 1950),
Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
May 1993, International journal of cancer,
Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
January 1991, International archives of allergy and applied immunology,
Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
November 1991, Vaccine,
Alejandro López-Requena, and Mabel Rodríguez, and Cristina Mateo de Acosta, and Ernesto Moreno, and Yaquelin Puchades, and Majela González, and Ariel Talavera, and Aisel Valle, and Tays Hernández, and Ana María Vázquez, and Rolando Pérez
December 1992, The Journal of experimental medicine,
Copied contents to your clipboard!